SureTrader
Home > Boards > US Listed > Biotechs > Delcath Systems, Inc. (DCTH)

np Sry8, remember you can pm 4-5 pm

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
toomuchmoney Member Profile
Member Level 
Followed By 199
Posts 14,234
Boards Moderated 0
Alias Born 03/11/01
160x600 placeholder
Delcath Systems to Present at Upcoming Investor Conferences "PR Newswire (US)" - 2/4/2016 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/22/2016 4:26:04 PM
Delcath Announces Initiation Of Phase 3 Trial Of Melphalan/HDS System For Treatment Of Hepatic Dominant Ocular Melanoma "PR Newswire (US)" - 1/20/2016 8:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 1/20/2016 6:03:38 AM
Delcath Announces Special Protocol Assessment Agreement With FDA For New Phase 3 Trial In Hepatic Dominant Ocular Melanoma "PR Newswire (US)" - 1/19/2016 8:00:00 AM
Delcath To Present At NobleCon12 Investor Conference "PR Newswire (US)" - 1/15/2016 10:18:00 AM
Review of Delcath Melphalan/HDS System Published in "Cardiovascular & Interventional Radiology" "PR Newswire (US)" - 1/11/2016 8:30:00 AM
Delcath Prior Phase 3 Trial Results Published In Annals Of Surgical Oncology "PR Newswire (US)" - 12/9/2015 8:59:00 AM
Delcath Announces CHEMOSAT Review Accepted for Publication in Cardiovascular and Interventional Radiology "PR Newswire (US)" - 12/8/2015 8:00:00 AM
Delcath Announces CHEMOSAT Treatment Milestones In Europe "PR Newswire (US)" - 12/2/2015 8:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 11/25/2015 4:10:01 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/25/2015 4:07:22 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 11/12/2015 4:16:09 PM
Delcath Systems To Host Business Update Conference Call On November 17, 2015 "PR Newswire (US)" - 11/11/2015 9:40:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/10/2015 4:10:56 PM
Delcath Reports 2015 Third Quarter Financial Results "PR Newswire (US)" - 11/10/2015 8:30:00 AM
Data Supporting Delcath's CHEMOSAT System Presented At The European Association Of Dermato Oncology Annual Congress "PR Newswire (US)" - 11/2/2015 8:30:00 AM
Delcath Announces First Patient Treated In ICC Cohort Of Global Phase 2 HCC Trial Program "PR Newswire (US)" - 10/15/2015 11:07:00 AM
Delcath Phase 3 Trial Results To Be Published In Annals Of Surgical Oncology "PR Newswire (US)" - 10/14/2015 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/9/2015 4:53:36 PM
Delcath Announces National Reimbursement Coverage For CHEMOSAT Procedures In Germany "PR Newswire (US)" - 10/8/2015 8:30:00 AM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 10/7/2015 5:18:31 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 10/6/2015 4:25:48 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/6/2015 4:21:27 PM
Delcath Systems Appoints CEO Jennifer Simpson To Board Of Directors "PR Newswire (US)" - 10/6/2015 8:00:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist